Clalit Health Organization, Jerusalem 9780214, Israel.
Faculty of Medicine, Hebrew University of Jerusalem, 9190401, Israel.
J Sex Med. 2023 Feb 27;20(3):324-331. doi: 10.1093/jsxmed/qdac040.
Dyspareunia affects approximately half of postpartum women and is attributed to multiple factors. Despite its high prevalence and resultant negative effects, data are lacking regarding the causes and different pain components, the usefulness of recommended treatments, and the prognosis.
To evaluate causes of postpartum dyspareunia, targeted treatment modalities, and their effectiveness.
A retrospective observational study was conducted of women diagnosed with postpartum dyspareunia between September 2008 and January 2017 at a single designated vulvovaginal disorder clinic. The inclusion criterion was complaint of painful intercourse commencing postdelivery. The cohort was divided into 4 groups based on the causes of dyspareunia: muscle hypertonicity, scar tenderness, vestibular tenderness, and atrophy.
The following were assessed for each group: patient background demographics, clinical and obstetric data, physical findings, recommended therapy, adherence to the suggested treatment, level of improvement at follow-up visits, and length of time until maximal improvement.
A hundred women met the inclusion criterion; the majority (n = 60) presented with >1 causative factor. The most common finding was vestibular tenderness (n = 78, 78%), which was significantly associated with atrophy (adjusted odds ratio [aOR], 15.08; 95% CI, 2.45-93.35), contraceptive usage (aOR, 4.76; 95% CI, 1.07-21.39), and primiparity (aOR, 4.89; 95% CI, 1.01-23.88). Episiotomy was the only risk factor for scar tenderness (aOR, 5.43; 95% CI, 1.20-24.53), while the existence of a spontaneous perineal tear was not. No specific correlation was found with pelvic floor muscle hypertonicity. Targeted treatment resulted in significant improvement in most patients.
A targeted diagnostic and treatment approach for postpartum dyspareunia is effective and can be beneficial for caregivers treating postpartum women.
A uniform and consistent protocol for patient selection and management is a major strength, which magnifies the clinical implication of our findings. The retrospective nature of the study is the primary limitation.
Postpartum dyspareunia is a common problem; however, many women refrain from discussing it with their providers. Therefore, it is important to assess this condition with all women during the postpartum visit as targeted diagnosis and treatment can significantly improve outcomes.
性交痛影响约半数产后女性,其病因众多。尽管其发病率高且后果严重,但有关病因和不同疼痛成分、推荐治疗方法的有效性,以及预后的数据仍十分缺乏。
评估产后性交痛的病因、针对性治疗方法及其疗效。
对 2008 年 9 月至 2017 年 1 月在一家指定的外阴阴道疾病诊所就诊的、诊断为产后性交痛的女性进行回顾性观察性研究。纳入标准为产后开始出现性交疼痛。根据性交痛的病因将患者分为 4 组:肌肉紧张、疤痕触痛、外阴触痛和萎缩。
评估每组患者的以下指标:患者背景人口统计学资料、临床和产科数据、体格检查结果、推荐的治疗方法、对建议治疗的依从性、随访时的改善程度以及达到最大改善所需的时间。
共有 100 名女性符合纳入标准,其中大多数(n=60)存在 1 种以上病因。最常见的发现是外阴触痛(n=78,78%),其与萎缩显著相关(调整后优势比[aOR],15.08;95%置信区间[CI],2.45-93.35),与避孕措施的使用(aOR,4.76;95% CI,1.07-21.39)和初产妇身份(aOR,4.89;95% CI,1.01-23.88)相关。会阴切开术是疤痕触痛的唯一危险因素(aOR,5.43;95% CI,1.20-24.53),而自然会阴撕裂则不是。与盆底肌肉紧张没有特定相关性。针对病因的治疗对大多数患者有效。
针对产后性交痛的针对性诊断和治疗方法是有效的,对于治疗产后女性的医护人员有益。
患者选择和管理的统一、一致的方案是一个主要优势,这放大了我们研究结果的临床意义。研究的回顾性是主要的局限性。
产后性交痛是一种常见问题;然而,许多女性不愿与提供者讨论该问题。因此,在产后访视时对所有女性评估该情况非常重要,因为针对性诊断和治疗可显著改善结局。